Nuclear Medicine/ Radio-pharmaceuticals Market

Table of Content

1. INTRODUCTION
   1. Study Assumptions and Market Definition
   2. Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
   1. Market Overview
   2. Market Drivers
      1. Continuous Regulatory Support for Accelerated Approvals
   3. Market Restraints
      1. Short Shelf-Life of Radiopharmaceuticals
      2. Supply Chain Shortcomings
   4. Market Opportunity
      1. Sharp Rise in Applications of Precision Medicines & Targeted Therapies
   5. Market Trends
      1. Exploring Novel Radioisotopes
      2. Optimizing Efficacy in Radiopharmaceuticals
5. MARKET SEGMENTATION
   1. By Type
      1. Diagnostic
      2. Therapeutic
   2. By Modality
      1. SPECT
      2. PET
      3. Alpha-emitters
      4. Beta-emitters
      5. Brachytherapy
   3. By Application
      1. Oncology
      2. Cardiology
      3. Neurology
      4. Thyroid
      5. Others
   4. By Procedures
      1. Oncology
      2. Cardiovascular
      3. Central Nervous System
      4. Endocrine
      5. Skeletal
      6. Gastrointestinal
      7. Genito-urinary
      8. Pulmonary
      9. PET & PET-CT
      10. Therapeutic
      11. Others
   5. By End-user
      1. Hospitals and diagnostic centers
      2. Research institutes
   6. By Key Geographic Regions
      1. North America
         1. United States
         2. Canada
         3. Mexico
      2. Europe
         1. Germany
         2. United Kingdom
         3. France
         4. Italy
         5. Spain
         6. Rest of Europe
      3. Asia Pacific
         1. China
         2. Japan
         3. India
         4. Australia
         5. South Korea
         6. Rest of Asia Pacific
      4. Middle East and Africa
         1. GCC
         2. South Africa
         3. Rest of Middle East and Africa
      5. South America
         1. Brazil
         2. Argentina
         3. Rest of South America
6. COMPETITIVE LANDSCAPE
   1. Company Profile
      1. Advanced Accelerator Applications S.A.
      2. Bayer AG
      3. Bracco Imaging S.p.A
      4. Curium
      5. Cardinal Health, Inc.
      6. Eczacibasi-Monrol Nuclear Products
      7. General Electric Co.
      8. GE Healthcare
      9. IBA Group
      10. Isotope JSC
      11. Jubilant Draximage Inc.
      12. Lantheus Medical Imaging, Inc.
      13. Medtronic, plc. (Covidien, acquired by Medtronic)
      14. Mallinckrodt plc.
      15. Nordion Inc.
      16. NorthStar Medical Radioisotopes
      17. NTP Radioisotopes SOC Ltd.
      18. PharmaLogic Holdings Corp.
      19. Siemens Healthineers

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

Frequently Asked Questions

Q.1. What is the projected market value of the global Nuclear Medicine/ Radio-pharmaceuticals market?

The global market of nuclear medicine/ radio-pharmaceuticals is projected to reach USD 15.5 Bn by 2033.

Q.2. What is the estimated growth rate (CAGR) of the global nuclear medicine/ radio-pharmaceuticalsmarket?

The global nuclear medicine/ radio-pharmaceuticals market has an estimated annual growth rate of 11.0% .

Q.3. What are the recent trends of nuclear medicine/ radio-pharmaceuticalsmarket?

Exploring novel radioisotopes as well as optimizing efficacy in radiopharmaceuticals are some of the major trends of the market that is projected to boost the market growth in the near future.

Q.4. Which are the top companies to hold the market share in nuclear medicine/ radio-pharmaceuticals?

The major companies profiled in this report include Advanced Accelerator Applications S.A., Bayer AG, Bracco Imaging S.p.A, Curium, Cardinal Health, Inc., Eczacibasi-Monrol Nuclear Products, General Electric Co., GE Healthcare, IBA Group, Isotope JSC, Jubilant Draximage Inc., Lantheus Medical Imaging, Inc., Medtronic, plc. (Covidien, acquired by Medtronic), Mallinckrodt plc., Nordion Inc., NorthStar Medical Radioisotopes, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Siemens Healthineers, among others.

Q.5. Which is the largest regional market in the nuclear medicine/ radio-pharmaceuticals?

North America is the largest regional market for nuclear medicine/ radio-pharmaceuticals.